Popp, Albrecht; Varathan, Nadshathra; Buffat, Helene; Senn, Christoph; Perrelet, Romain; Lippuner, Kurt (2018). Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis. Calcified tissue international, 103(1), pp. 50-54. Springer 10.1007/s00223-018-0394-4
|
Text
Popp2018_Article_BoneMineralDensityChangesAfter.pdf - Published Version Available under License Publisher holds Copyright. Download (1MB) | Preview |
The aim of the present study was to document the changes in bone mineral density (BMD) 1 year after denosumab loss-of-effect following long-term treatment with subcutaneous denosumab 60 mg Q6M during 7 or 10 years and in the absence of any treatment with a bone active substance. All postmenopausal women with osteoporosis who participated to the randomized placebo-controlled FREEDOM core trial and its open-label extension at the University Hospital of Bern, Switzerland, and who accepted to undergo off-treatment follow-up during 1 year after discontinuation, were included (N = 12). After 10 years of denosumab, mean lumbar spine (LS) BMD had increased by 21.2% vs. baseline. One year after discontinuation LS BMD had decreased by - 9.1% vs. Year 10, resulting in a net gain of 10.2% vs. baseline. At total hip (TH) and femoral neck (FN), BMD had increased by 8.3 and 8.1% in Year 10 vs. baseline, respectively. 1 Year after discontinuation, BMD had decreased by - 12.7 and - 11.0% vs. Year 10, respectively, corresponding to net BMD losses of - 5.5 and - 3.8% vs. baseline, respectively. Similar albeit less pronounced changes were observed in those treated with denosumab during 7 years. Stopping denosumab after long-term exposure resulted in BMD losses of large order of magnitude at all measured sites, suggesting that treatment duration may predict the rate and amount of bone lost.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Osteoporosis |
UniBE Contributor: |
Popp, Albrecht, Buffat, Helene, Senn, Christoph, Perrelet, Romain, Lippuner, Kurt |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0171-967X |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Romain Perrelet |
Date Deposited: |
27 Dec 2018 15:38 |
Last Modified: |
05 Dec 2022 15:22 |
Publisher DOI: |
10.1007/s00223-018-0394-4 |
PubMed ID: |
29380013 |
Uncontrolled Keywords: |
Bone mineral density Denosumab Long-term therapy Osteoporosis Rebound-associated bone loss |
BORIS DOI: |
10.7892/boris.122235 |
URI: |
https://boris.unibe.ch/id/eprint/122235 |
Actions (login required)
 |
Edit item |